logo
  

ANI Pharmaceuticals, Inc. Q4 Earnings Summary

Below are the earnings highlights for ANI Pharmaceuticals, Inc. (ANIP):

Earnings: -$4.65 million in Q4 vs. -$24.33 million in the same period last year.
EPS: -$0.28 in Q4 vs. -$1.72 in the same period last year.
Excluding items, ANI Pharmaceuticals, Inc. reported adjusted earnings of $12.44 million or $0.76 per share for the period.

Revenue: $94.23 million in Q4 vs. $60.93 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT